Renal Vascular Reactivity in Hypertension
Renal Vascular Reactivity in Hypertension
批准号:
8588946
负责人:
WILLIAM J ARENDSHORST
金额:
$58.44万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-09-01 至 2015-11-30
关键词:
ADP-ribosyl CyclaseAbnormal CellAcuteAdenosine DiphosphateAffinityAgonistAmericanAngiotensin IIAnimalsArteriesAtherosclerosisAttenuatedBindingBlood VesselsBlood VolumeChronicConsciousContractsDevelopmentDiabetes MellitusDinoprostDiseaseEndothelinEndothelin-1EnzymesEventExcretory functionExhibitsFamily memberFlowmetryFundingG-Protein-Coupled ReceptorsGene TargetingGeneticGoalsHealthHormonesHypertensionImageInfusion proceduresIon ChannelIsoprostanesKidneyKidney FailureKnock-outKnockout MiceMeasuresMediatingMembraneMessenger RNAMicrocirculationModelingMolecularMusNAD+ NucleosidaseNatriuresisNitratesNitric OxideNitritesOxidative StressPathogenesisPathway interactionsPhasePhysiologicalPhysiologyPlayPositioning AttributeProductionRegulationRenal functionResistanceRoleRyanodine ReceptorsSecond Messenger SystemsSeveritiesSignal PathwaySignal TransductionSmall Interfering RNASmooth Muscle MyocytesSodium ChlorideStrokeSystemTelemetryTestingThromboxane ReceptorThromboxanesUltrasonicsVascular DiseasesVasoconstrictor AgentsWaterWild Type MouseWorkarterioleblood pressure regulationcalcium metabolismcardiovascular risk factordensitygenetic manipulationin vivokidney cortexkidney vascular structureknock-downnovelpressureradioligandreceptorresponsetoolurinaryvasoconstriction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
CD38 ADP ribosyl (ADPR) cyclase is a membrane-bound enzyme that produces metabolites known to
promote Ca2+ mobilization mediated by ryanodine receptors (RyR) in arteriolar smooth muscle cells. We posit
that renal CD38 is central to the development of angiotensin II (Ang II)-induced hypertension (AIH) and that
CD38-deficient mice exhibit less pronounced renal vasoconstriction, Na+ retention and AIH than do wild-type
(WT) mice. AIM 1 tests the hypothesis that CD38 ADPR cyclase participates in the development of AIH such
that Ang II produces less pronounced hypertension in CD38-/- (global genetic deficiency) vs. WT mice. Less
severe hypertension is also predicted in WT mice with targeted, renal-specific partial knockdown of CD38
induced by siRNA. The severity of AIH is determined by measuring 24-hr arterial pressure (telemetry) in
conscious, unrestrained mice before and during chronic Ang II infusion. Also measured are 24 hr urinary
excretion of nitrite/nitrate and 8-iso-PGF2¿ to assess nitric oxide (NO) production and oxidative stress. CD38
mRNA and ADPR cyclase activity will be quantified in preglomerular vessels. AIM 2 assesses the contribution
of CD38 ADPR cyclase to renal vasoconstriction and the rightward shift in the pressure-natriuresis relation in
AIH. We predict that the kidneys of CD38-deficient mice excrete Na+ more rapidly in response to an acute salt
load than WT mice during development of AIH, with excretion rates becoming similar in established AIH.
Conscious and anesthetized mice with global knockout and renal-specific knockdown of CD38 will be
evaluated in both phases. AIM 3 evaluates the hypothesis that CD38 is the major ADPR cyclase mediating G-
protein coupled receptor-elicited Ca2+ signaling involving RyR and Ca2+-induced Ca2+ release in isolated
afferent arterioles and renal vasoconstriction in vivo. We predict that Ca2+ signaling and vascular
responsiveness to vasoconstrictor agents (Ang II, ET-1, TxA2) are attenuated in CD38-deficient vs. WT mice
during control and AIH conditions. Scatchard analysis of radioligand binding will characterize Ang II, ET-1,
and TP receptor affinity and/or density in renal microvessels. Our goal is to identify a sequence of events that
precede or occur early during the development of hypertension and thus are more likely to be causative than
secondary, pressure-dependent consequences. Combining gene-targeted deletion of CD38, global and renal-
specific, with pharmacological inhibition of ADPR cyclase and RyR-mediated Ca2+ release will provide
important new information that CD38 is the primary cyclase family member mediating Ca2+ signaling in the
renal microcirculation and its functional significance in long-term regulation of renal vasoconstriction, Na+
retention and the development of AIH. Successful completion of our novel studies of this underappreciated
pathway will significantly advance our understanding of cellular/molecular mechanisms of Ca2+ signaling in the
renal microcirculation and regulation of renal vascular reactivity in health and disease, making a major impact
on the field.
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.cmet.2010.05.015
发表时间:
2010-08-04
期刊:
Cell metabolism
影响因子:
29
作者:
[Yang D, Luo Z, Ma S, Wong WT, Ma L, Zhong J, He H, Zhao Z, Cao T, Yan Z, Liu D, Arendshorst WJ, Huang Y, Tepel M, Zhu Z]
通讯作者:
Zhu Z
DOI:
10.1046/j.1523-1755.2000.00329.x
发表时间:
2000-10
期刊:
Kidney international
影响因子:
19.6
作者:
[S. Fellner;W. Arendshorst]
通讯作者:
S. Fellner;W. Arendshorst
DOI:
10.1152/ajprenal.1999.277.4.f533
发表时间:
1999-10
期刊:
American journal of physiology. Renal physiology
影响因子:
--
作者:
[S. Fellner;W. Arendshorst]
通讯作者:
S. Fellner;W. Arendshorst
Short-term ANG II produces renal vasoconstriction independent of TP receptor activation and TxA2/isoprostane production.
短期 ANG II 产生独立于 TP 受体激活和 TxA2/异前列烷产生的肾血管收缩。
DOI:
10.1152/ajprenal.00510.2006
发表时间:
2007
期刊:
American journal of physiology. Renal physiology
影响因子:
--
作者:
[Vågnes,ØyvindB, Iversen,BjarneM, Arendshorst,WilliamJ]
通讯作者:
Arendshorst,WilliamJ
Alpha1-adrenoceptor subtypes on rat afferent arterioles assessed by radioligand binding and RT-PCR.
通过放射性配体结合和 RT-PCR 评估大鼠传入小动脉的 α1-肾上腺素受体亚型。
DOI:
10.1152/ajprenal.2001.281.1.f172
发表时间:
2001
期刊:
American journal of physiology. Renal physiology
影响因子:
--
作者:
[Salomonsson,M, Oker,M, Kim,S, Zhang,H, Faber,JE, Arendshorst,WJ]
通讯作者:
Arendshorst,WJ
共 22 条
FASEB Conference: Renal Hemodynamics: Biomolecular Control Mechanisms Integrating
-
批准号:7329023
-
项目类别:
-
资助金额:$1.3万
-
财政年份:2007
-
负责人:WILLIAM J ARENDSHORST
-
依托单位:
MICROPUNCTURE STUDY OF KIDNEY FUNCTION
-
批准号:2026982
-
项目类别:
-
资助金额:$33.42万
-
财政年份:1986
-
负责人:WILLIAM J ARENDSHORST
-
依托单位:
Renal Vascular Reactivity in Genetic Hypertension
-
批准号:7143355
-
项目类别:
-
资助金额:$50.07万
-
财政年份:1986
-
负责人:WILLIAM J ARENDSHORST
-
依托单位:
Renal Vascular Reactivity in Genetic Hypertension
-
批准号:7472526
-
项目类别:
-
资助金额:$50.55万
-
财政年份:1986
-
负责人:WILLIAM J ARENDSHORST
-
依托单位:
Renal Vascular Reactivity in Genetic Hypertension
-
批准号:6890434
-
项目类别:
-
资助金额:$45.4万
-
财政年份:1986
-
负责人:WILLIAM J ARENDSHORST
-
依托单位:
MICROPUNCTURE STUDY OF KIDNEY FUNCTION
-
批准号:6182486
-
项目类别:
-
资助金额:$36.51万
-
财政年份:1986
-
负责人:WILLIAM J ARENDSHORST
-
依托单位:
MICROPUNCTURE STUDY OF KIDNEY FUNCTION
-
批准号:6388365
-
项目类别:
-
资助金额:$37.61万
-
财政年份:1986
-
负责人:WILLIAM J ARENDSHORST
-
依托单位:
Renal Vascular Reactivity in Hypertension
-
批准号:8383467
-
项目类别:
-
资助金额:$56.06万
-
财政年份:1986
-
负责人:WILLIAM J ARENDSHORST
-
依托单位:
MICROPUNCTURE STUDY OF KIDNEY FUNCTION
-
批准号:2702067
-
项目类别:
-
资助金额:$31.95万
-
财政年份:1986
-
负责人:WILLIAM J ARENDSHORST
-
依托单位:
MICROPUNCTURE STUDY OF KIDNEY FUNCTION
-
批准号:2910469
-
项目类别:
-
资助金额:$35.45万
-
财政年份:1986
-
负责人:WILLIAM J ARENDSHORST
-
依托单位:
MICROPUNCTURE STUDY OF KIDNEY FUNCTION
-
批准号:2209960
-
项目类别:
-
资助金额:$31.39万
-
财政年份:1986
-
负责人:WILLIAM J ARENDSHORST
-
依托单位:
MICROPUNCTURE STUDY OF KIDNEY FUNCTION
-
批准号:3334128
-
项目类别:
-
资助金额:$29.62万
-
财政年份:1986
-
负责人:WILLIAM J ARENDSHORST
-
依托单位:
Renal Vascular Reactivity in Genetic Hypertension
-
批准号:6621652
-
项目类别:
-
资助金额:$42.79万
-
财政年份:1986
-
负责人:WILLIAM J ARENDSHORST
-
依托单位:
Renal Vascular Reactivity in Genetic Hypertension
-
批准号:6435555
-
项目类别:
-
资助金额:$41.55万
-
财政年份:1986
-
负责人:WILLIAM J ARENDSHORST
-
依托单位:
Renal Vascular Reactivity in Hypertension
-
批准号:8050304
-
项目类别:
-
资助金额:$57.43万
-
财政年份:1986
-
负责人:WILLIAM J ARENDSHORST
-
依托单位:
MICROPUNCTURE STUDY OF KIDNEY FUNCTION
-
批准号:3334136
-
项目类别:
-
资助金额:$30.06万
-
财政年份:1986
-
负责人:WILLIAM J ARENDSHORST
-
依托单位:
Renal Vascular Reactivity in Genetic Hypertension
-
批准号:7275953
-
项目类别:
-
资助金额:$50.08万
-
财政年份:1986
-
负责人:WILLIAM J ARENDSHORST
-
依托单位:
Renal Vascular Reactivity in Genetic Hypertension
-
批准号:7643237
-
项目类别:
-
资助金额:$53.13万
-
财政年份:1986
-
负责人:WILLIAM J ARENDSHORST
-
依托单位:
Renal Vascular Reactivity in Genetic Hypertension
-
批准号:6744354
-
项目类别:
-
资助金额:$44.08万
-
财政年份:1986
-
负责人:WILLIAM J ARENDSHORST
-
依托单位:
MICROPUNCTURE STUDY OF KIDNEY FUNCTION
-
批准号:2209962
-
项目类别:
-
资助金额:$34.02万
-
财政年份:1986
-
负责人:WILLIAM J ARENDSHORST
-
依托单位:
海外基金